Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

127 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Video

    Webinar Video | Life Sciences Session #2: Vaccine Liability: What If Vaccination Goes Wrong?

    The ongoing vaccination campaign against Covid-19 raises the question of possible side effects and of the potential liability for damages arising from the use of vaccines used against this disease.
    BelgiumCoronavirus (COVID-19)
    ALTIUS
    ALTIUS
  • Article

    Regulator Proposes Reducing Requirements For Radiation-Emitting Products

    In a welcome move, on 1 April 2019 the U.S. Food and Drug Administration (FDA) proposed reducing regulatory requirements for a number of radiation-emitting electronic products.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    WEBINAR VIDEO | Navigating Mergers And Acquisitions In Life Sciences: Insights For Success And Pitfalls To Avoid

    During this webinar, the experts from our assembled transactions team, Richard Liu, Mieke D'hanis and Pauline Geentjens, provide valuable insights, inform you of common pitfalls...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 53

    This regular update (no. 53 | 28 June 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines...
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    Commission Guidelines For Providers Of General-purpose AI Models

    On July 18, 2025, the European Commission released its guidelines on the obligations for providers of general-purpose AI (GPAI) models under the European Union's AI Act.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Commission Fines Servier And 5 Other Generic Producers A Total Of € 427 Million Over "Pay-For-Delay" Deals And Abuse Of A Dominant Position

    Perindopril is a blood pressure control medicine that used to be Servier’s bestselling medicine.
    European UnionIntellectual Property
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    Podcast: Talking The Cure

    Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    EMA's CHMP Recommends Approval Of Six New Biosimilars

    The European Medicines Agency's (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Council Position On EU Pharma Package Adopted

    On 4 June, the Council of the European Union (Council) adopted its negotiation position on the proposals for a new regulation and directive that make up the so-called ‘pharma package'.
    European UnionFood, Drugs, Healthcare, Life Sciences
    A&O Shearman
    A&O Shearman
  • Article

    Belgian Constitutional Court Strikes Down Pharma Industry 'Unavailability Contribution'

    The Belgian Constitutional Court ("CC"), on 6 November 2025, annulled some provisions of the Law of 18 May 2024 containing various provisions on health and finance...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    How Medical Technology Is Navigating The AI Act In Europe

    AI is revolutionizing medical products and manufacturing, from remote surgery to diagnostics, prompting regulators to catch up. The EU AI Act, effective since August, aims to address the industry's evolving challenges. Experts discuss its potential impact on medical technology.
    BelgiumTechnology
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Draft Common Specifications For Products Without An Intended Medical Purpose

    On 14 January 2022, the European Commission published a draft Implementing Regulation laying down the Common Specifications for the groups of products without an intended medical purpose...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 44

    This regular update (no. 44 | 21 April 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical ..
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 50

    This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    European Commission Adopts Directive Extending Time Lead Can Be Used In PVC Sensors Of IVDs

    The European Commission has adopted Commission Delegated Directive (EU) 2023/1526, which amends Directive 2011/65/EU of the European Parliament and European Council...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Video

    Webinar Video | Lunch & Learn: Life Sciences : Morceaux Choisis

    Ce webinar porte sur les sciences du vivant et est composé de deux parties: 'Ecueils et dangers pour la protection de la recherche & du développement dans le secteur du vivant.
    BelgiumGovernment, Public Sector
    ALTIUS
    ALTIUS
  • Article

    Podcast: Talking The Cure - March 4, 2020

    Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    Commission Sends Statement Of Objections To Lundbeck, Servier And Others Over "Pay-For-Delay" Agreements; Third Patent Settlement Monitoring Report Published

    On 25 July 2012, the European Commission announced that it had sent a formal Statement of Objections ("SO") to Danish pharmaceutical company Lundbeck over its conclusion of so-called "pay-for-delay" agreements with four generic producers of citalopram, a antidepressant medicine.
    European UnionIntellectual Property
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    European Parliament Adopts Its Version Of AI Act

    On June 14, 2023, an overwhelming majority of the European Parliament (Parliament) recently voted to pass the Artificial Intelligence Act (AI Act), marking another major step toward the legislation becoming law.
    European UnionTechnology
    Arnold & Porter
    Arnold & Porter
  • Article

    European Union And United States Agree On Import Tariffs For Pharmaceutical Products

    On 21 August 2025, the European Union and the United States published a Joint Statement (JS) "on a United States-European framework on an agreement on reciprocal...
    GlobalInternational Law
    Van Bael & Bellis
    Van Bael & Bellis
  • Showing 1–20 of 127 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics